Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared on LinkedIn:
“On World Lung Cancer Day, let’s take a minute to underscore the power of science in shifting the narrative for lung cancer (especially NSCLC).
- Since 2013, immune and targeted therapies have helped reduce mortality dropped by more than double prior rates
- Key trials show patients live months longer, and a growing share now survives 3–5+ years.
At the Parker Institute for Cancer Immunotherapy (PICI), we are investing in what comes next: next generation immunotherapeutics, combination strategies, and fast-tracking breakthroughs to patients. We believe that every life extended (and every life saved!) is a reminder of what is possible when science leads.”
More posts featuring World Lung Cancer Day.